Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Electronic Batch Record (EBR) Entry – V 2.0

Posted on By


Biosimilars: SOP for Electronic Batch Record (EBR) Entry – V 2.0


Standard Operating Procedure for Electronic Batch Record (EBR) Entry in Biosimilar Upstream Manufacturing

Department Biosimilars
SOP No. SOP/BS/103/2025
Supersedes SOP/BS/103/2022
Page No. Page 1 of 12
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for accurate, timely, and compliant entry of manufacturing process data into the Electronic Batch Record (EBR) system during upstream biosimilar production, in alignment with data integrity and GMP principles.

2. Scope

This SOP applies to all upstream operations including media preparation, inoculation, seed train expansion, bioreactor runs, and harvest activities where electronic records are maintained within the biosimilars manufacturing department.

3. Responsibilities

  • Production Operator: Enter data into the EBR system in real-time and ensure completeness.
  • Production Supervisor: Review and verify EBR entries at defined checkpoints.
  • QA: Audit and approve final EBRs before batch disposition.

4. Accountability

The Manufacturing Head is accountable for ensuring that electronic batch records are complete, traceable, and comply with 21 CFR Part 11 requirements.

5. Procedure

5.1 Access Control

  1. All personnel must have unique login credentials issued by the IT Administrator.
  2. Access is role-based and logged with time stamps in audit trails.
  3. Do not share login information or use generic credentials.

5.2 Real-Time Data Entry

  1. Enter all process values (temperature, pH, DO, agitation, pressure) as they occur or within 15 minutes of execution.
  2. For automated entries (from SCADA), verify synchronization and correctness daily.
  3. Manual entries must include operator initials and entry date/time.

5.3 Data Verification and Review

  1. Supervisor shall verify each section for:
    • Completeness
    • Legibility
    • Proper units
    • Timestamp consistency
  2. Mark reviewed sections as “Verified” with supervisor’s electronic signature.

5.4 Deviation Documentation

  1. In case of discrepancy or deviation, raise a deviation record from within the EBR interface and cross-reference deviation number.
  2. Link associated CAPA documentation as required.

5.5 Batch Record Lock and Submission

  1. Upon completion of upstream activities:
    • Lock the EBR to prevent further editing.
    • Submit for QA review via the workflow engine.

5.6 Backup and Data Integrity

  1. All EBR data must be backed up daily to secure, validated servers.
  2. Data must be retained for a minimum of 7 years.

6. Abbreviations

  • EBR: Electronic Batch Record
  • SCADA: Supervisory Control and Data Acquisition
  • CAPA: Corrective and Preventive Action
  • QA: Quality Assurance

7. Documents

  1. EBR Daily Entry Log – Annexure-1
  2. EBR Deviation Summary – Annexure-2

8. References

  • 21 CFR Part 11 – Electronic Records and Signatures
  • WHO TRS 996 – GMP for Electronic Documentation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: EBR Daily Entry Log

Date Parameter Value Entered By Verified By
04/05/2025 pH 7.1 Sunita Reddy Ajay Verma

Annexure-2: EBR Deviation Summary

Deviation ID Date Description Link to CAPA Status
EBR-DEV-014 04/05/2025 Omitted DO reading at 10:00 CAPA-105 Closed

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Included audit trail and backup retention procedures Regulatory compliance update
See also  Biosimilars: SOP for Viral Inactivation via Low pH Treatment - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Reconciliation of Materials Used in Manufacturing – V 2.0
Next Post: Elixir Department: SOP for Filtering Through Stainless Steel Screens – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version